DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for ChemoCentryx, Inc. (CCXI)
« Back to company indexCCXI Chatter Timeline
Stock Ticker for CCXI
Most Active Tweeters for CCXI
| User | Tweets |
|---|---|
| @Tickeron | 14 |
| @gcassidy718 | 6 |
| @HealthcareBeat | 5 |
| @stocknewstimes | 3 |
| @semodough | 3 |
Recent Tweets for CCXI
 |
@Tickeron $CCXI's 10-day Moving Average broke below its 50-day Moving Average on March 17, 2020. View odds for this and other… https://t.co/2iqaOerqhz April 2nd 2020, 12:04pm |
|
@Tickeron $CCXI enters an Uptrend because Momentum Indicator exceeded the 0 level on March 30, 2020. View odds for this and o… https://t.co/Nh6ru2hZHv April 1st 2020, 2:04pm |
 |
@AmericanBanking -$0.30 EPS Expected for ChemoCentryx Inc $CCXI This Quarter https://t.co/BkNDcYc361 #stocks April 1st 2020, 10:04am |
 |
@stocknewstimes -$0.30 EPS Expected for ChemoCentryx Inc $CCXI This Quarter https://t.co/FCuGmh3SpX April 1st 2020, 10:04am |
 |
@dakotafinancial -$0.30 EPS Expected for ChemoCentryx Inc $CCXI This Quarter https://t.co/jqyInWF2gJ April 1st 2020, 10:04am |
 |
@ConsumerFeed Zacks: Analysts Anticipate ChemoCentryx Inc $CCXI Will Post Earnings of -$0.30 Per Share https://t.co/OH6c5ssgUj April 1st 2020, 10:04am |
 |
@semodough $VRTX will report 1Q20 results including potential impact of COVID-19 on CF product sales. $CCXI will report Phase… https://t.co/S6V8p7FU38 April 1st 2020, 6:04am |
 |
@InsiderAlertsIA $CCXI: New Insider Filing on ChemoCentryx, Inc.'s Principal Acctg Officer PUI SAN KWAN: https://t.co/IrHAzCX4Cv April 1st 2020, 6:04am |
 |
@BioPharmaWolf @juliaskripkaser No sympathy move for $CCXI Avacopan lol April 1st 2020, 5:04am |
 |
@jeromeleonard5 @juliaskripkaser $ccxi discussed potential of this last cc. Seemed like a valid target. They are probably not getti… https://t.co/vcPZK12iUr April 1st 2020, 3:04am |
 |
@1MinuteStock Do you know that #Book Value for $CCXI is $1.1 https://t.co/H3Xjxvifnd April 1st 2020, 3:04am |
|
@1MinuteStock We calculated 63-day Expected Return of $CCXI for you: 15.12% https://t.co/UWhwbtw53i April 1st 2020, 1:04am |
 |
@Philips_247 RT @InsiderAlertsIA: $CCXI: New Insider Filing on ChemoCentryx, Inc.'s Director RITA JAIN: https://t.co/NjfOaLLvDD March 31st 2020, 8:03pm |
|
@InsiderAlertsIA $CCXI: New Insider Filing on ChemoCentryx, Inc.'s Director RITA JAIN: https://t.co/NjfOaLLvDD March 31st 2020, 8:03pm |
 |
@HealthcareBeat 16,510 shares acquired by Kwan Pui San (Principal Acctg Officer), reported in a new form 4 filed with the SEC $CCXI https://t.co/IqI7YinD7e March 31st 2020, 8:03pm |
 |
@SnackBioTech @Orangeman1992 @JamesEKrause $CCXI has held up well this past month so I don't expect it to get any major bumps fro… https://t.co/dYvSRwYN4r March 31st 2020, 7:03pm |
 |
@VisualStockRSRC $CCXI - Statement of Changes in Beneficial Ownership (4) https://t.co/J3offwrEZW March 31st 2020, 7:03pm |
|
@HealthcareBeat 5,251 shares acquired by Jain Rita (Director), reported in a new form 4 filed with the SEC $CCXI https://t.co/RMb8gWKJkK March 31st 2020, 7:03pm |
|
@Tickeron $CCXI's price moved below its 50-day Moving Average on March 16, 2020. View odds for this and other indicators:… https://t.co/NEC9vWvViL March 31st 2020, 12:03pm |
|
@Tickeron $CCXI enters a Downtrend as Momentum Indicator dropped below the 0 level on March 27, 2020. View odds for this and… https://t.co/3qDkjFAMnv March 30th 2020, 11:03am |
 |
@jdcaetano @VenetoLibero198 After selling $CCXI after PIII trail in ANCA, I haven't done too much I do think $LYV has a busin… https://t.co/iEkmDZqlXo March 29th 2020, 6:03pm |
 |
@gcassidy718 $CCXI Hurting with one -3.41 % change recently https://t.co/euTK18qFmi March 29th 2020, 2:03pm |
|
@Tickeron $CCXI enters a Downtrend because Momentum Indicator dropped below the 0 level on March 27, 2020. View odds for this… https://t.co/oU3dfvhh7s March 29th 2020, 11:03am |
|
@HealthcareBeat Insider Selling: ChemoCentryx Inc Director Sells $1,101,000.00 in Stock $CCXI https://t.co/YCwkcUjfTV March 29th 2020, 4:03am |
|
@ConsumerFeed Insider Selling: ChemoCentryx Inc $CCXI Director Sells $1,101,000.00 in Stock https://t.co/7oYMP6jbIu March 29th 2020, 4:03am |
|
@stocknewstimes Insider Selling: ChemoCentryx Inc $CCXI Director Sells $1,101,000.00 in Stock https://t.co/RyckhbHkxm March 29th 2020, 4:03am |
|
@gcassidy718 $CCXI here we go!! -3.41 % change recently https://t.co/euTK18qFmi March 28th 2020, 2:03pm |
|
@Tickeron $CCXI enters a Downtrend because Momentum Indicator dropped below the 0 level on March 27, 2020. View odds for this… https://t.co/Z8HU6NRzjV March 28th 2020, 12:03pm |
 |
@ThisLincolnian Geoffrey M. Parker Sells 30,000 Shares of ChemoCentryx Inc $CCXI Stock https://t.co/HgOQEYKtZl March 28th 2020, 4:03am |
|
@dakotafinancial Geoffrey M. Parker Sells 30,000 Shares of ChemoCentryx Inc $CCXI Stock https://t.co/3NJAjQweHY March 28th 2020, 4:03am |
 |
@TranscriptDaily Geoffrey M. Parker Sells 30,000 Shares of ChemoCentryx Inc $CCXI Stock https://t.co/tDd1zm5mRu March 28th 2020, 4:03am |
|
@semodough $CCXI view LUMINA-1 / FSGS as an attractive call option with favorable reward / risk profile (potential for ~10-40%… https://t.co/5mxQqlNWtu March 27th 2020, 9:03pm |
|
@Tickeron $CCXI enters an Uptrend as Momentum Indicator exceeded the 0 level on March 26, 2020. View odds for this and other… https://t.co/4Iv35FUaEO March 27th 2020, 1:03pm |
|
@biostockinfo RT @semodough: Nice update by JP $CCXI Thinking About 2Q LUMINA-1 CCX140 FSGS Readout & Scenario Analysis Overweight Top-line data from t… March 26th 2020, 4:03pm |
|
@semodough Nice update by JP $CCXI Thinking About 2Q LUMINA-1 CCX140 FSGS Readout & Scenario Analysis Overweight Top-line da… https://t.co/0VVl3o8psW March 26th 2020, 3:03pm |
|
@Tickeron $CCXI enters a Downtrend as Momentum Indicator dropped below the 0 level on March 5, 2020. View odds for this and o… https://t.co/ZrcizBZSyo March 26th 2020, 12:03pm |
 |
@TickerReport Geoffrey M. Parker Sells 30,000 Shares of ChemoCentryx Inc $CCXI Stock https://t.co/HtneDmfQh4 March 26th 2020, 5:03am |
|
@AmericanBanking Geoffrey M. Parker Sells 30,000 Shares of ChemoCentryx Inc $CCXI Stock https://t.co/lMXpgTj7L9 #stocks March 26th 2020, 5:03am |
 |
@insiderbuyings $CCXI new insider selling: 30000 shares. https://t.co/XBsgYx1S89 March 26th 2020, 3:03am |
 |
@BlueBioNow $CCXI Valuation is starting to make more sense now $33.98. https://t.co/MERF23zxao March 26th 2020, 1:03am |
 |
@ResearchPool $CCXI #ChemoCentryx Inc Chemocentryx Inc: 1 director sold: A director at Chemocentryx Inc sold 30,000 shares at 36.… https://t.co/J5gqiYUpCY March 25th 2020, 11:03pm |
|
@MonitorAction $CCXI Geoffrey Parker sells $1.1M Worth Of ChemoCentryx, Inc. Stock https://t.co/C43z4uLwJv March 25th 2020, 10:03pm |
|
@HealthcareBeat $1,101,126.41 of shares sold by Parker Geoffrey M. (Director), reported in a new form 4 filed with the SEC $CCXI https://t.co/WbGB5WLW8D March 25th 2020, 10:03pm |
|
@VisualStockRSRC $CCXI - Statement of Changes in Beneficial Ownership (4) https://t.co/neuPgLMjKt March 25th 2020, 6:03pm |
 |
@fintel_io Insider Parker Geoffrey M. reports selling 30,000 shares of $CCXI for a total cost of $1,101,048.96 https://t.co/O9JV58YASP March 25th 2020, 6:03pm |
|
@Tickeron $CCXI's Aroon indicator reaches into Uptrend on March 24, 2020. View odds for this and other indicators:… https://t.co/VFFnGFA2G4 March 25th 2020, 3:03pm |
 |
@path1finder $CCXI looks to be a great biotech though $2.3b market cap is quite something. If only I knew how strong it can corr… https://t.co/l4drwKc08Z March 25th 2020, 2:03pm |
|
@gcassidy718 $CCXI I'll have my bear burger medium rare with mushroom and swiss please. 4.90 % change recently https://t.co/euTK18qFmi March 25th 2020, 12:03am |
|
@Tickeron $CCXI's Aroon indicator reaches into Uptrend on March 23, 2020. View odds for this and other indicators:… https://t.co/xCArfFauNN March 24th 2020, 4:03pm |
|
@Tickeron $CCXI's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/5aFUy1MdO4 March 23rd 2020, 3:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.